Performing Multiple Regulatory Requirements within a Program Such as GMP, GLP, GCP, Medical Devices, and/or Controlled Substances

Size: px
Start display at page:

Download "Performing Multiple Regulatory Requirements within a Program Such as GMP, GLP, GCP, Medical Devices, and/or Controlled Substances"

Transcription

1 Performing Multiple Regulatory Requirements within a Program Such as GMP, GLP, GCP, Medical Devices, and/or Controlled Substances

2 Performing Multiple Regulatory Requirements within a Program Such as GMP, GLP, GCP, Medical Devices, and/or Controlled Substances Pharma work may require multiple GXP programs GMP GLP DEA Medical Device GCP These may include special training practices, documentation efforts, facility and equipment processes, interactions from one regulation to another as well as the monitoring of record keeping and reporting. Attempting to run multiple programs may fail if: Duplicate procedures are provided with conflicting requirements

3 Overview Establishing a Quality Management System The Umbrella of the QMS Reinforcement of Top Management Continued Support Developing a Quality Team of All Stakeholders Providing feedback to groups

4 Quality Management System Defines the Organization Establishes Leadership and Management Senior management acting as role models for how all employees should work

5 Quality Management System Team Project Team Quality Assurance Management

6 Certified Quality System A quality management system (QMS) is essential in today s market Strong marketing tool Limits competition due to cost and required infrastructure Provides clients with assurances that systems are under control Focuses staff on improvement, compliance, and customer satisfaction

7 Integration of Multiple QMSs under ISO 9001 DEA ISO GLP 58, 160 USDA GMP 211 AR 50 6 ISO 9001 NQA1 DOE/ DOD NELAC (EPA)

8

9 Good Manufacturing Practice (cgmp) 21 CFR Part 11 Compliance for Software 21 CFR Part 210 Current GMP in Manufacturing, Processing, Packing, or Holding of Drugs; General; 21 CFR Part 211 Current GMP Practice in Finished Pharmaceuticals 9

10 Good Laboratory Practice (GLP) FDA (Food & Drug Administration; 40 CFR Part 58) FDA is proposing to amend regulations to require a complete quality system approach Announced Aug 2016 EPA FIFRA (Federal Insecticide, Fungicide & Rodent Act; 40 CFR Part 160) EPA TSCA (Toxic Substance Control Act; 40 CFR Part 792) 10

11 Medical Devices ISO 13485:2003 Medical Devices Quality Management Quality Requirement Manual (QRM) Revision 2 Project Quality Plans 21 CFR Part 820 Food And Drug Administration Department Of Health And Human Services Subchapter H Medical Devices 11

12 ISO 9001:2015 Quality System Controlled notebooks Controlled procedures Quality Records Archived Division 01 Traceability Software and Hardware controls Design control Quality Project Plan Training Corrective Actions (QRS) Internal Audits

13 Drug Enforcement Agency (DEA) (Department of Justice) All projects involving controlled substances requires a DEA license for either manufacturing or research Licenses maintained by the Legal Department

14 DEA (Drug Enforcement Agency) Pharmaceutical programs may involve controlled substances requiring Traceability Audit trail Special Reporting Secure & Limited Access to drug Accountability DEA registration

15 DEA Research/Manufacturing Research Traceability Zero tolerance Locked cabinet Limited access Signed DEA access ISO Requirements DEAAudit Potential Surveillance to control DEA Training Biennial Inventory Manufacturing Traceability Zero tolerance Regulation Safe Limited access Signed DEA access ISO Requirements DEA Audit Definite ARCOS Requirements DEA Training Biennial Inventory EOY Inventory

16 Integration of Multiple QMSs under ISO 9001 ISO DEA GLP 58, 160 ISO 9001 USDA GMP 211 NELAC (EPA)

17 The ISO Umbrella The ISO 9001 is the umbrella that allows the organization to meet other regulatory requirements. Procedures required by other program are already identified in the ISO 9001 SOPs

18 ISO 9001:2015 Minimums The ISO Procedures on all Projects for all Division 01 Staff Document Control Forms, TAPs, Plans, Notebooks Data Control and Reporting A minimum for all reports to paying clients Training Some regulatory groups have zero tolerance for delinquent training i.e. FDA Calibration Of any measurement activity Evaluate Risks Approved Supplier List For all class 1 items At the manufacturing facility not the distributor Nonconforming processes, procedures If we do not document the problem and corrective action the auditor/client will define as a finding

19

20 ISO 9001 Establishes criteria for a quality management system Used across all industries, organizations and countries Based on a number of quality principles Customer focus Leadership Engagement of people Process approach Improvement Evidenced-based decision making Relationship management

21 Organization/ Personnel Facilities Equipment Risk Document Control Purchasing CAPA Records and Reports ISO 9001 cgmp 21 CFR Part 211 GLP 21 CFR Part CFR Part 160 GCP 21 CFR Part 312 Medical Device ISO CFR Part 820 DEA 21 CFR Part 1300 QA for GMP GMP Recalls OOS Validation Qualification BSE/TSE Stability Study Dev. Study Director Protocol Final Report QAU Master Schedule Clinical Study CRO Randomization Monitor Human Subject IRB Bioavailability Device Record Design Review Design Transfer Cert. Mark Investigation Informed Consent Form 222 Inventory Use & Tracking ACROS EOY Inventory Quota

22 Develop The Quality Team (Quality Circle)

23 Quality Management System Document Control Organization and Responsibility Evaluation of Risk Opportunities Computer Hardware/Software Management Review Qualification and Training Laboratory Notebooks Requirements Data Control and Reporting Storage and Maintenance of Quality Records Control of Measuring and Test Equipment Monitoring and Measurement Preparation/Review/Approval of Proposals and Contracts Purchasing Control of Customer Supplied Items Handling, Storage, Packaging Protection, and Delivery of Items Customer Feedback/Complaints Internal/External Quality Audits Nonconforming Material Quality System Trending CAPA Program

24 Risk Evaluation Required in 9001, GMP, Medical Device, DEA, but beneficial in other regs

25 Once the key SOPs are developed the required procedures may apply to multiple programs One time documents When revised, the revision is one time. Avoids the need for multiple revisions Most programs require 70 to 90% of the SOPs identified Titles of the main SOP are general to other requirements Provide the main SOPs as a controlled document for all Audits Sub SOPs as needed may be added to the QMS to avoid duplicate procedures

26 MANAGEMENT REVIEW Management review allows the QMS for Trending and Reporting Identify a Quality Program within your CAPA System This allows each program to be trended by defect code Minimizes efforts of multiple programs for management review

27 Document/Change Control Involves initial request for all documents Revisions needed during review Notebooks Protocols Plan Form Change Control (GMP/Medical Device/GCP) Reason for Change Documents affected QA Approval prior to change Follow up and Close out of Change

28

29

30

31 Quality is not Free!! Creation of initial processes Preparing Standard Operating Procedures Review and Approvals Initial and continual training Quality Assurances Plans for projects Documentation Calibration and documentation of compliance Demonstration of competency 25 to 45 external client or regulatory audits per year Archiving results and studies

32 Benefits of Quality? Each audit has the umbrella procedures for ease Added Program procedures are effective Continual Improvements due to the additional audits Repetitiveness throughout all programs Efficient Systems Compliance Continuous training repetitiveness Customer retention New Customers Growth for different programs

33

34 Leadership and Management Most programs require Management as leaders and continual support of the program All ISO programs going through revisions Top Management shall demonstrate leadership and commitment by. GLP Testing facility management shall.. Medical Device Executive responsibility shall ensure. DEA Reports to highest level of management..

35 LEADS PROJECTS TOP MANAGEMENT COMMITMENT TO QUALITY AND INTEGRITY CULTURE AND FINANCE ACCOUNTABLE LEADERSHIP AND MANAGMENT DECISION AND PROBLEM SOLVERS PERFORMANCE AND INTEGRITY MANAGEMENT

36 How to Initiate a New QMS to current programs Establish the QMS elements and procedures Develop SOPs and review for the QMS elements Train to the new QMS SOPs and explain the tiered effects Incorporate the new QMS by merging the existing programs: Review each program SOP and delete duplicate SOPs to the new SOP Check remaining program SOPs for reference to those duplicates and reference new SOP replacing the duplicate Program Quality Program Plans are helpful to reference all documents associated Train to the completed programs Reinforce the new references in existing documents

37 Adding a New Program to the QMS Consider a Quality Program Plan (QPP) The plan identifies the minimal program elements The QPP will identify current SOPs developed in the umbrella QMS Establish additional elements required for the new program Review the QPP to reference the new SOPs for the new program Train staff involved in the new program to QPP and emphasize reference documents New documents for the new program Utilize this process for program auditors

38 JoAnn Boyd, MBA Quality Assurance Manager Southwest Research Institute (210)

GxP Auditing, Remediation, and Quality System Resourcing

GxP Auditing, Remediation, and Quality System Resourcing GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing 8

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

Quality Manual. Index

Quality Manual. Index This quality policy manual is for the use of, its Clients, Vendors, and the appropriate Regulatory Agencies. Unauthorized duplication or transfer to others is prohibited. Index Authorization... 3 Introduction...

More information

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management The Impact of Quality Culture on Quality Risk Management FDA Perspective on Quality Culture; how it Impacts Risk Management Teresa Gorecki Practice Lead Compliance Architects Agenda The WHAT Definitions

More information

Electronic Records and Electronic Signatures (21 CFR Part 11)

Electronic Records and Electronic Signatures (21 CFR Part 11) Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003 Electronic Records and Electronic Signatures (21 CFR Part 11) Hans-Beat Jenny, SwissMedic, Basel

More information

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines Longe Sunday Anthony Head- Quality Assurance May & Baker Nigeria Plc. Pharmacentre, Ota, Nigeria eaglesconsult@gmail.com; Slonge@may-

More information

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 11 Status : APPROVED Effective: 09/07/2017 Page 2 of 32 Quality Manual Table of Contents

More information

GCP Basics - refresher

GCP Basics - refresher p. 01 GCP Basics - refresher Agenda: p. 02 Brief History of GCP GCP Regulations Principles of ICH E6 Sponsor Responsibilities Computer Systems Common Compliance Issues Brief History of GCP 3 Brief History

More information

QUALITY MANUAL. This document defines the requirements, processes, structure and documentation for the Teledyne DGO Quality Management System.

QUALITY MANUAL. This document defines the requirements, processes, structure and documentation for the Teledyne DGO Quality Management System. Page 1 of 13 1. PURPOSE This document defines the requirements, processes, structure and documentation for the Teledyne DGO Quality Management System. 2. SCOPE The Teledyne DGO Quality Management System

More information

For analytical laboratories. A primer Good laboratory practice and current good manufacturing practice

For analytical laboratories. A primer Good laboratory practice and current good manufacturing practice For analytical laboratories A primer Good laboratory practice and current good manufacturing practice For analytical laboratories A primer Good laboratory practice and current good manufacturing practice

More information

Risk-based Approach to Part 11 and GxP Compliance

Risk-based Approach to Part 11 and GxP Compliance Welcome to our E-Seminar: Risk-based Approach to Part 11 and GxP Compliance 1 Intro Common Discussion Q: Do I really need to do this? Possible Answers A: Of course! (QA) B: Who cares, I have work to do!

More information

Curriculum Vitae Dr. Joachim Schoch-Bösken. jsb-validierung Zwischen den Bächen 9 D Rheinfelden

Curriculum Vitae Dr. Joachim Schoch-Bösken. jsb-validierung Zwischen den Bächen 9 D Rheinfelden Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 176 42 60 85 72 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de

More information

Testo Expert Knowledge. The GxP Dictionary 1st edition. Definitions relating to GxP and Quality Assurance

Testo Expert Knowledge. The GxP Dictionary 1st edition. Definitions relating to GxP and Quality Assurance Testo Expert Knowledge The GxP Dictionary 1st edition Definitions relating to GxP and Quality Assurance Note: Some of the information contained in this GxP Dictionary does not apply equally to all countries.

More information

Understanding GxP Regulations for Healthcare

Understanding GxP Regulations for Healthcare Understanding GxP Regulations for Healthcare GxP Guidelines What is GxP? GxP is a collection of quality guidelines and regulations created to ensure that bio/pharmaceutical products are safe, meet their

More information

a n d B i o s a fety C o n s i d e ra t i o n s

a n d B i o s a fety C o n s i d e ra t i o n s National University of Singapore Academy of GxP Excellence (NUSAGE) & PharmEng Technology Presents Good Laboratory Practices a n d B i o s a fety C o n s i d e ra t i o n s Part of the Pharmaceutical and

More information

Vendor Qualification Survey

Vendor Qualification Survey 1200 West 96 th St Minneapolis, MN 55431 Ph: 952-888-7900 Fax: 952-888-2719 Vendor Qualification Survey Vendor Information Company Name: Date: Address: City: Phone Number: email address: Product or Service

More information

GMP On Site Series. GMP Essentials

GMP On Site Series. GMP Essentials GMP On Site Series GMP Essentials GMP Basics Objectives 1. State the critical definitions of the pharmaceutical industry. 2. Describe the law as it applies to various critical functions. 3. State the history

More information

GENERIC CHECKLIST FOR GLP/GXP INSPECTIONS/AUDITS

GENERIC CHECKLIST FOR GLP/GXP INSPECTIONS/AUDITS Appendix A: GENERIC CHECKLIST FOR GLP/GXP INSPECTIONS/AUDITS Example of an Audit Checklist Organization and Personnel Yes No NA Organizational chart exists and accurately represents the organization? Is

More information

KINGSMANN CARE GROUP

KINGSMANN CARE GROUP PHARMA CONSULTANTS KINGSMANN CARE GROUP KINGSMANN CONSULTANCY SERVICES Thank you for taking interest in Kingsmann Consultancy Services. Kingsmann Consultancy (KC) is a leading business development-consulting

More information

Prevent Quality System Deficiencies by Conducting Effective Internal Audits. Whitepaper

Prevent Quality System Deficiencies by Conducting Effective Internal Audits. Whitepaper Prevent Quality System Deficiencies by Conducting Effective Internal Audits Whitepaper An internal audit system is one of the most effective ways to monitor, analyze, control, and improve quality management

More information

Journal home page: RESEARCH ARTICLE

Journal home page:  RESEARCH ARTICLE Journal home page: http://www.journalijiar.com INTERNATIONAL JOURNAL OF INNOVATIVE AND APPLIED RESEARCH RESEARCH ARTICLE QUALITY AUDIT AND GMP INSPECTION OF PHARMACEUTICAL INDUSTRY WITH REFERENCE TO USFDA;

More information

GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando

GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando GLP Computerized Systems Updates from OECD Guidance Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando 1 Validation EPA GLP Obligation Expectations of the EPA for Computers in GLP (40 CFR

More information

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.

More information

Process Validation for Active Pharmaceutical Ingredients (API)

Process Validation for Active Pharmaceutical Ingredients (API) National University of Singapore Academy of GxP Excellence (NUSAGE) and PharmEng Technology Presents Process Validation for Active Pharmaceutical Ingredients (API) Part of the Pharmaceutical and Biotechnology/Training

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

OECD and EPA GLP Differences

OECD and EPA GLP Differences OECD and EPA GLP Differences Annette Leslie RQAP-GLP Du Pont Pioneer Ankeny Iowa I conduct studies in the US, so Why do I care about oecd regulations? Disclaimer: I cannot cover all the differences in

More information

Library Guide: Active Pharmaceutical

Library Guide: Active Pharmaceutical Library Guide: Active Pharmaceutical Ingredients (API) Table of Contents Overview...3 Sample Curriculum...5 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)...7 A Tour of the

More information

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11. References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which

More information

OCTC 2012 CRO Selection

OCTC 2012 CRO Selection OCTC 2012 CRO Selection Colin Macaulay Viron Therapeutics Inc. 15 Nov 2012 Viron Therapeutics Inc. Virtual Biotech Company (6) Phase 2a (48 pt) clinical trial in acute coronary syndrome (ACS) completed

More information

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA SOP#: 014.5 Date Issued: 11/00 Date Revised: 8/15 Page 1 of 5 TITLE: SCOPE: RESPONSIBILITY: PURPOSE: Research

More information

QUALITY SYSTEM MANUAL

QUALITY SYSTEM MANUAL TITLE: QUALITY SYSTEM MANUAL Page 1 of 15 QUALITY SYSTEM MANUAL TITLE: QUALITY SYSTEM MANUAL Page 2 of 15 Index PARAGRAPH TITLE... PAGE 1.0 GENERAL INFORMATION... 3 2.0 DEFINITIONS... 5 3.0 RELATED DOCUMENTS...

More information

EFFECTIVE CLINICAL TRIALS. NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program. Copyright 2014 NUSAGE-PharmEng.

EFFECTIVE CLINICAL TRIALS. NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program.  Copyright 2014 NUSAGE-PharmEng. EFFECTIVE CLINICAL TRIALS NUSAGE PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry EFFECTIVE CLINICAL TRIALS Objective The intent

More information

QMS CO-ORDINATOR & GENERAL PROCEDURES:-

QMS CO-ORDINATOR & GENERAL PROCEDURES:- 1. QMS CO-ORDINATOR & GENERAL PROCEDURES:- (1) How do you measure effectiveness of system for working of your company? How do you collect necessary information for the same? Are you getting information

More information

QUALIFICATIONS PACK - OCCUPATIONAL STANDARDS FOR LIFE SCIENCES INDUSTRY SUB-SECTOR: PHARMACEUTICAL OCCUPATION: QUALITY ASSURANCE

QUALIFICATIONS PACK - OCCUPATIONAL STANDARDS FOR LIFE SCIENCES INDUSTRY SUB-SECTOR: PHARMACEUTICAL OCCUPATION: QUALITY ASSURANCE h QUALIFICATIONS PACK - OCCUPATIONAL STANDARDS FOR LIFE SCIENCES INDUSTRY Contents What are Occupational Standards (OS)? OS describe what individuals need to do, know and understand in order to carry out

More information

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between

More information

QA Services. Global. GCP - GVP - GLP - GMP Audits Computer System Compliance Mock Inspections SOP Development Benchmarking and Risk Management

QA Services. Global. GCP - GVP - GLP - GMP Audits Computer System Compliance Mock Inspections SOP Development Benchmarking and Risk Management Global QA Services GCP - GVP - GLP - GMP Audits Computer System Compliance Mock Inspections SOP Development Benchmarking and Risk Management QMS Consultancy Due Diligence Gap Analysis Training ADAMAS is

More information

Stability Studies for Pharmaceutical Products (API and finished products)

Stability Studies for Pharmaceutical Products (API and finished products) A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry Stability Studies for Pharmaceutical Products (API and finished products)

More information

Understanding GxP (GMP, GCP & GLP) for FDA Regulated Industries

Understanding GxP (GMP, GCP & GLP) for FDA Regulated Industries Microrite, Inc. brings you this unique learning experience in Understanding GxP (GMP, GCP & GLP) for FDA Regulated Industries; Part of Microrite s step-by-step webinar series. Understanding GxP (GMP, GCP

More information

Strategies for Risk Based Validation of Laboratory Systems

Strategies for Risk Based Validation of Laboratory Systems Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,

More information

GLP Compliance Assurance vs. Quality Assurance. Quality Beyond GLP Compliance

GLP Compliance Assurance vs. Quality Assurance. Quality Beyond GLP Compliance GLP Compliance Assurance vs. Quality Assurance Quality Beyond GLP Compliance Jennifer Pangborn Quality Assurance Specialist 1 Outline Why QAU is here? Quality Assurance beyond GLP Compliance Expanding

More information

OUT OF SPECIFICATION. SASIDA YOOSOOK 4 April 2014

OUT OF SPECIFICATION. SASIDA YOOSOOK 4 April 2014 OUT OF SPECIFICATION SASIDA YOOSOOK 4 April 2014 ISO 17025:2005 4.9 Control of nonconforming testing and/or calibration work 4.9.1 The laboratory shall have a policy and procedures that shall be implemented

More information

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines

More information

DECISION TO ACCREDIT

DECISION TO ACCREDIT DECISION TO ACCREDIT Determine the requirements of the regulator, legislation and customer s needs prior to deciding on the standard to implement. Process is based on the following: Top management s decision

More information

GOOD LABORATORY PRACTICE (GLP)

GOOD LABORATORY PRACTICE (GLP) GOOD LABORATORY PRACTICE (GLP) Series Catalog CITI Program s GLP series provides an overview of how nonclinical laboratory studies should be planned, performed, monitored, recorded, reported, and archived

More information

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide.

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide. Computerised Systems Wholesale Distribution Information Day, Alfred Hunt Inspector Date Insert on Master Slide Slide 1 Index What is a computerised system Updates to EU GDPs Expectations Case studies Slide

More information

George Bernstein, Ph.D. Double Dragon Consulting

George Bernstein, Ph.D. Double Dragon Consulting George Bernstein, Ph.D. Double Dragon Consulting 9/30/2008 Copyright 2016 George Bernstein The Problem The Solution Quality Standards vs. SOPs Example Quality Standards Clinical Development Pharmacovigilance

More information

AAMI Quality Systems White Paper

AAMI Quality Systems White Paper AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017, Updated February 2018 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward,

More information

FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru

FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru FDA QSR (21 CFR Part 820) ISO 13485:2016 820.1 Scope 1 Scope 2 Normative References 820.3 Definitions 3 Terms and Definitions

More information

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS Francesco Amorosi PhD Octorber 2017 DATA INTEGRITY & CSV:

More information

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible

More information

Introduction to 21 CFR 11 - Good Electronic Records Management

Introduction to 21 CFR 11 - Good Electronic Records Management INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Review Article Introduction to 21 CFR 11 - Good Electronic Records Management Pal Tapas Kumar* and Maity Subhasis NSHM Knowledge Campus,

More information

I. DEFINITION This training under Kilimanjaro School of Pharmacy Industrial Pharmacy Teaching Unit (IPTU) is an Advanced Training Program in Drug Development, Drug Manufacturing, Regulatory & Quality Compliance.

More information

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits Quality Assurance QA 601.01 STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval: Frederick

More information

Laboratory Quality Assurance Manager & Laboratory Assessor RULES & HANDBOOK

Laboratory Quality Assurance Manager & Laboratory Assessor RULES & HANDBOOK EOQ Personnel Registration Scheme Laboratory Quality Assurance Manager & RULES & HANDBOOK Prepared by: Dr. Eugenia Soboleva, Quality Austria In accordance with the working group on EOQ product development

More information

Quality Management System Plan

Quality Management System Plan Quality Management System Plan Rev. 2 February, 2004 Shaw Environmental & Infrastructure, Inc. 4171 Essen Lane Baton Rouge, LA 70809 Page iii Rev. 2 Table of Contents PAGE Approvals Quality Policy &

More information

Data Collection Tools Functions, Indicators & Sub-Indicators

Data Collection Tools Functions, Indicators & Sub-Indicators Data Collection Tools 27- Functions, Indicators & A. National regulatory system Indicator RS1: Legal framework for establishment of a regulatory system, mandate and enforcement power for each function

More information

1 The Clinical Research Coordinator (CRC)... 1

1 The Clinical Research Coordinator (CRC)... 1 TABLE OF CONTENTS Dedication... iii Introduction... xi 1 The Clinical Research Coordinator (CRC)... 1 Role and Responsibilities of the CRC...1 Personality and Skills... 3 Where Do CRCs Work?... 3 CRC Responsibilities...

More information

Supplier Quality Agreements

Supplier Quality Agreements Supplier Quality Agreements Dan O Leary CBA, CQA, CQE, CRE, SSBB, CIRM President Ombu Enterprises, LLC Dan@OmbuEnterprises.com www.ombuenterprises.com 603-209-0600 OMBU ENTERPRISES, LLC 1 Outline QSR Requirements

More information

LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY:

LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY: LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY: QUESTIONS TO ASK AND RESPONSIBILITIES TO DOCUMENT Heather Longden Boston Chapter Educational Meeting April 2018 About Waters Lab Informatics Separations

More information

General Requirements for the Competence of Testing and Calibration Laboratories

General Requirements for the Competence of Testing and Calibration Laboratories ISO 17025:2005 POSITION PAPER General Requirements for the Competence of Testing and Calibration Laboratories EXECUTIVE SUMMARY This position paper provides a high-level overview of how LabVantage supports

More information

Chapter 1 GALP Overview

Chapter 1 GALP Overview 2185 1995 Ed. GOOD AUTOMATED LABORATORY PRACTICES Chapter 1 GALP Overview 1. PURPOSE Most of the health and environmental data EPA uses in its regulatory programs are analyzed in and reported by laboratories.

More information

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC)

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC) Overview of USFDA Drug Regulatory Requirements Pharmaceutical Quality and Facility Inspections (GMP) Session II 19 February 2014 Casablanca, Morocco GMP The Other Side of Chemistry, Manufacturing & Controls

More information

Standard Operating Procedures Guidelines for Good Clinical Practice

Standard Operating Procedures Guidelines for Good Clinical Practice SOP # CRSC-105 Effective Date 10-22-2013 Version # 1 Version Date 7-30-2013 Standard Operating Procedures Guidelines for Good Clinical Practice Purpose: This SOP outlines the steps required to follow FDA

More information

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents Guidance for s Regulatory File Essential s All principal investigators must maintain a regulatory binder or file system, which contains all study documentation. These records may be reviewed at the time

More information

0. 0 TABLE OF CONTENTS

0. 0 TABLE OF CONTENTS QUALITY MANUAL Conforming to ISO 9001:2008 0. 0 TABLE OF CONTENTS Section Description ISO 9001 Clause Page 0 TABLE OF CONTENTS n/a 2 1 PIMA VALVE, INC. DESCRIPTION n/a 3 2 QUALITY MANUAL DESCRIPTION 4.2.2

More information

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017 CSV Inspection Readiness through Effective Document Control Eileen Cortes April 27, 2017 Agenda Background CSV Readiness CSV and Change Management Process Inspection Readiness Do s and Don ts Inspection

More information

Supplier Audit Procedure /20/17

Supplier Audit Procedure /20/17 1.0 Purpose The purpose of this procedure is to establish a process for conducting a Supplier audit to determine if the Supplier has a quality system, if the Supplier follows an established quality system,

More information

Mark Citriglia Manager of Analytical Services Northeast Ohio Regional Sewer District

Mark Citriglia Manager of Analytical Services Northeast Ohio Regional Sewer District Mark Citriglia Manager of Analytical Services Northeast Ohio Regional Sewer District Licensure Non-voluntary process by which a government agency regulates and grants permission for an individual to engage

More information

The interface between Good Clinical Practice and Good Manufacturing Practice

The interface between Good Clinical Practice and Good Manufacturing Practice 1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who

More information

Outsource or in-house? The evolving role of analytical services in pharmaceutical manufacturing

Outsource or in-house? The evolving role of analytical services in pharmaceutical manufacturing Outsource or in-house? The evolving role of analytical services in pharmaceutical manufacturing By Impact Analytical Introduction About Impact Analytical Impact Analytical is a contract analytical testing

More information

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd. Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd. Copyright 2009 - Pharmaceutical Research & Manufacturers Association 1 Overview Audit ICH-GCP,

More information

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP)

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) GMP Requirements Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) 2016. ALL RIGHTS RESERVED. Outline GMP Procedures and standards

More information

SUPPLIER QUALITY SYSTEM SURVEY

SUPPLIER QUALITY SYSTEM SURVEY SUPPLIER QUALITY SYSTEM SURVEY DATE (M/d/yy): 55 Dragon Court Woburn, MA 01801 Tel: (781) 933-7300 Fax: (781) 935-4529 GENERAL INFORMATION Supplier Name: Physical Address: City: State: Zip: Sr. Company

More information

Correlation matrices between ISO 9001:2008 and ISO 9001:2015

Correlation matrices between ISO 9001:2008 and ISO 9001:2015 Correlation matrices between ISO 9001:2008 and ISO 9001:2015 ISO 9001:2015 ISO 9001:2008 1 Scope 1 Scope 1.1 General 4 Context of the organization 4 Quality management system 4.1 Understanding the organization

More information

Correspondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements

Correspondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements Correspondence Between and 21 CFR Part 820 QMS Requirements 10411 Corporate Drive, Suite 102, Pleasant Prairie, WI 53158 262.842.1250 262.842.1240 info@rcainc.com rcainc.com 2 4 Quality Management System

More information

EU and FDA GMP Regulations: Overview and Comparison

EU and FDA GMP Regulations: Overview and Comparison THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational

More information

How to Set Up and Manage Quality Control and Quality Assurance

How to Set Up and Manage Quality Control and Quality Assurance How to Set Up and Manage Quality Control and Quality Assurance Myriam Visschedijk 1, *, Rik Hendriks 2 and Katrien Nuyts 3 1 TNO Quality of Life, The Netherlands 2 Johnson & Johnson Pharmaceutical Research

More information

Supplies and Reagents

Supplies and Reagents Supplies and Reagents PACT Workshop: Design & Operation of GMP Cell Therapy Facilities April 4 th /5 th, 2006 NHLBI-sponsored PACT Group Guidance for Industry INDs Approaches to Complying with CGMP During

More information

HACCP audit checklist

HACCP audit checklist Requirement HACCP audit checklist Prerequisite Program Management Commitment 1. Senior management ensures that the responsibilities and authorities are defined and communicated within the company Internal

More information

Clinical Trials and the Code of Federal Regulations. Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014

Clinical Trials and the Code of Federal Regulations. Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014 Clinical Trials and the Code of Federal Regulations Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014 The Development of Regulations 1906: Food and Drugs Act

More information

Ensure Data Integrity Compliance in the Analytical Laboratory A Life Cycle Approach

Ensure Data Integrity Compliance in the Analytical Laboratory A Life Cycle Approach Ensure Data Integrity Compliance in the Analytical Laboratory A Life Cycle Approach Paresh Patel Director, Scientific Operations Johnson& Johnson QS&S 12/14/2016 1 1 Topics GMP regulatory requirements

More information

Software Quality Regulatory Trends

Software Quality Regulatory Trends Software Quality Regulatory Trends By Praxis Life Sciences 1925 West Field Court, Suite 125, Lake Forest, IL 60045 praxislifesciences.com +1(847) 295-7160 validationcenter.com Software Quality Regulatory

More information

Please type your questions in the Question section of the dashboard we will take questions at the conclusion of this presentation.

Please type your questions in the Question section of the dashboard we will take questions at the conclusion of this presentation. All participants have been muted. Please type your questions in the Question section of the dashboard we will take questions at the conclusion of this presentation. Please note that copies of today s presentation

More information

An Introduction to Double Dragon Consulting

An Introduction to Double Dragon Consulting An Introduction to Double Dragon Consulting www.doubledragonconsulting.com 1 June 2012 About DDC Our Experience: All dosage forms, aseptic processes, OTC Remediation of 483 observations, warning letters,

More information

Enabling Improvement through the Product Lifecycle: Change Management within a PQS

Enabling Improvement through the Product Lifecycle: Change Management within a PQS Enabling Improvement through the Product Lifecycle: Change Management within a PQS Denise DiGiulio, Senior Advisor OPQ Office of Process and Facilities PDA Chapter Meeting Melbourne, Australia April 3,

More information

Quality Manual ISO 9001:2000

Quality Manual ISO 9001:2000 Quality Manual ISO 9001:2000 Page 2 of 23 TABLE OF CONTENTS COVER PAGE...1 TABLE OF CONTENTS...2 SIGNATURES...3 QUALITY POLICY...4 INTRODUCTION...5 CORPORATE PROFILE...9 4.O QUALITY MANAGEMENT SYSTEM...10

More information

Design Qualification SOP

Design Qualification SOP 1.0 Commercial in Confidence 16-Aug-2006 1 of 13 Design Qualification SOP Document No: SOP_0400 Prepared by: David Brown Date: 16-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 16-Aug-2006 2 of 13

More information

Supplier Audit Procedure /2/17

Supplier Audit Procedure /2/17 1.0 Purpose The purpose of this procedure is to establish a process for conducting a Supplier audit to determine if the Supplier has a quality system, if the Supplier follows an established quality system,

More information

ICH Q8/Q8(R)

ICH Q8/Q8(R) Pharmaceutical Quality for the 21 st Century Temple University May 06, 2008 Joseph Famulare, Deputy Director FDA CDER Office of Compliance CDER Office of Compliance and the Critical Path Initiative Since

More information

GCP Refresher and GCP/GCDMP Trends. in the CTN. Denise King, MS, RD, CCRA & Lauren Yesko, BS. Presented by:

GCP Refresher and GCP/GCDMP Trends. in the CTN. Denise King, MS, RD, CCRA & Lauren Yesko, BS. Presented by: GCP Refresher and GCP/GCDMP Trends Presented by: in the CTN Denise King, MS, RD, CCRA & Lauren Yesko, BS CTN WEB SEMINAR SERIES: A FORUM TO EXCHANGE RESEARCH KNOWLEDGE Produced by: CTN Training This training

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Training and Development SOP-QMS-007 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s)

More information

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1 AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward, Owner, Ward Sciences

More information

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec 2004 Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland cca@iol.ie 1 FDA Context 1) FDA 5-Part Strategic Plan Protect &

More information

SKYCOAT, LLC QUALITY CONTROL MANUAL

SKYCOAT, LLC QUALITY CONTROL MANUAL QUALITY MANUAL SKYCOAT, LLC QUALITY CONTROL MANUAL Rev. 4 Rev. 2 1 TABLE OF CONTENTS Introduction 1 Organization 1.1 Scope 1.2 Scope Description 1.2.1 Scope Exclusions 1.2.2 Normative References 2.0 Terms

More information

Quality Assurance in Clinical Trials

Quality Assurance in Clinical Trials Quality Assurance in Clinical Trials Doctor Catherine CORNU, Lyon clinical Investigation Centre EUDIPHARM December 5th, 2011 1 Introduction: quality in clinical research in human subjects Regulatory requirements:

More information

21CFR11 Compliance and Automated Manufacturing

21CFR11 Compliance and Automated Manufacturing Presented at the World Batch Forum North American Conference Woodcliff Lake, NJ April 7-10, 2002 107 S. Southgate Drive Chandler, Arizona 85226-3222 480-893-8803 Fax 480-893-7775 E-mail: info@wbf.org www.wbf.org

More information